Skip to content

Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare

Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02544581
Enrollment
300
Registered
2015-09-09
Start date
2015-09-30
Completion date
2015-11-30
Last updated
2015-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorder

Brief summary

This is an exempt, retrospective study of a limited set of information obtained from patients' medical records at 10 to 12 substance abuse treatment programs combined with alcohol breath analyzer results during up to 3 years of aftercare monitoring. The study objectives are 1) to compare the compliance rates and likelihood of achieving sustained sobriety for aftercare patients in mandated (eg, impaired professionals) versus non-mandated monitoring programs and 2) identify components within patients' monitoring agreements that are significantly correlated with positive outcomes.

Interventions

OTHERSoberlink combined with aftercare services

Soberlink Alcohol Breath Analyzer System combined with aftercare services

Sponsors

SoberLink, LLC
Lead SponsorINDUSTRY

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Adults with a diagnosis of alcohol abuse enrolled into an aftercare program following residential treatment

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Compliance rates (negative versus positive versus false positive alcohol test findings)Test administered 2 to 4 times per day for up to 3 years
Response rates: defined as use of device when prompted-will include several values such as missed, late, excusedTest administered 2 to 4 times per day for up to 3 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026